Supporting Health Professionals

Providing resources and information for health professionals within the Gold Coast region

Gold Coast PHN is an independent, not-for-profit organisation, funded by the Commonwealth Department of Health and Aged Care.

We are committed to building a healthy, connected, and resilient community and do this by working with General Practice, pharmacists, nurses, allied health professionals, residential aged care facilities, hospitals and an array of secondary care providers to keep Gold Coasters out of hospital living happier, healthier and longer in the community.

Latest News

Important update: hardcopy MyMedicare patient registration forms

Since the introduction of hardcopy MyMedicare patient registration forms, numerous forms have been incorrectly sent to Services Australia, instead of being submitted to the relevant practice for processing. The Department of Health and Aged Care has been working with Services Australia since October...

EOI: free emergency planning software for general practice

Be prepared for a disaster or emergency with fully subsidised ERPT for general practice Gold Coast Primary Health Network is providing funded access to the Emergency Response Planning Tool (ERPT) for general practices from 8 May 2024 with limited spaces available. What is the ERPT? The ERPT is an on...

New CareSearchgp App: A tool supporting GPs to provide end-of-life care

CareSearch is an Australian Government funded National Palliative Care project providing trustworthy evidence-based information and resources on palliative care. It recently released its CareSearchgp app, a free digital tool to support GPs to deliver palliative care. The app brings together guidance...

Immunisation for the prevention of Respiratory Syncytial Virus (RSV) in infants

Queensland Health has introduced the Queensland Paediatric Respiratory Syncytial Virus Prevention Program (QPRSVP) to provide free RSV immunisation to eligible Queensland infants and young children. IMPORTANT – All infants born on or from 1 February 2024: Offered Nirsevimab as a dose at time o...